456 related articles for article (PubMed ID: 35724919)
1. Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment.
Sun K; Yu J; Hu J; Chen J; Song J; Chen Z; Cai Z; Lu Z; Zhang L; Wang Z
Acta Biomater; 2022 Aug; 148():230-243. PubMed ID: 35724919
[TBL] [Abstract][Full Text] [Related]
2. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
[TBL] [Abstract][Full Text] [Related]
3. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale Coordination Polymers for Synergistic NO and Chemodynamic Therapy of Liver Cancer.
Hu Y; Lv T; Ma Y; Xu J; Zhang Y; Hou Y; Huang Z; Ding Y
Nano Lett; 2019 Apr; 19(4):2731-2738. PubMed ID: 30919635
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
7. Tumor Acidic Microenvironment-Responsive Promodulator Iron Oxide Nanoparticles for Photothermal-Enhanced Chemodynamic Immunotherapy of Cancer.
Chen S; Lv Y; Wang Y; Kong D; Xia J; Li J; Zhou Q
ACS Biomater Sci Eng; 2023 Feb; 9(2):773-783. PubMed ID: 36598463
[TBL] [Abstract][Full Text] [Related]
8. Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination.
Feng W; Shi W; Cui Y; Xu J; Liu S; Gao H; Zhu S; Liu Y; Zhang H
Theranostics; 2023; 13(15):5266-5289. PubMed ID: 37908730
[TBL] [Abstract][Full Text] [Related]
9. A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death.
Huang H; Huang Y; Chen Y; Luo Z; Zhang Z; Sun R; Wan Z; Sun J; Lu B; Zhang L; Hu J; Li S
Biomaterials; 2021 Mar; 270():120708. PubMed ID: 33578254
[TBL] [Abstract][Full Text] [Related]
10. HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy.
Zhang X; He C; He X; Fan S; Ding B; Lu Y; Xiang G
J Control Release; 2023 Apr; 356():649-662. PubMed ID: 36933701
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable copper-metformin nanoscale coordination polymers for enhanced chemo/chemodynamic synergistic therapy by reducing oxygen consumption to promote H
Meng X; Zhang X; Lei Y; Cao D; Wang Z
J Mater Chem B; 2021 Mar; 9(8):1988-2000. PubMed ID: 33511387
[TBL] [Abstract][Full Text] [Related]
12. Repolarizing tumor-associated macrophages by layered double hydroxide-based deacidification agent for tumor chemodynamic therapy and immunotherapy.
Chen C; Zhang W; Lu SY; Wang J; Tan Y; Zhao S; Ouyang Y; Xu L; Zhou B; Yin X; Ran H; Liu H
Colloids Surf B Biointerfaces; 2023 Mar; 223():113157. PubMed ID: 36716658
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions.
Gao H; Cao Z; Liu H; Chen L; Bai Y; Wu Q; Yu X; Wei W; Wang M
Theranostics; 2023; 13(6):1974-2014. PubMed ID: 37064867
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Chemodynamic Therapy by Cu-Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction.
Koo S; Park OK; Kim J; Han SI; Yoo TY; Lee N; Kim YG; Kim H; Lim C; Bae JS; Yoo J; Kim D; Choi SH; Hyeon T
ACS Nano; 2022 Feb; 16(2):2535-2545. PubMed ID: 35080370
[TBL] [Abstract][Full Text] [Related]
16. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
[TBL] [Abstract][Full Text] [Related]
17. Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment.
Li L; Zhen M; Wang H; Sun Z; Jia W; Zhao Z; Zhou C; Liu S; Wang C; Bai C
Nano Lett; 2020 Jun; 20(6):4487-4496. PubMed ID: 32407113
[TBL] [Abstract][Full Text] [Related]
18. Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy.
Li X; Zhou Q; Japir AAMM; Dutta D; Lu N; Ge Z
ACS Nano; 2022 Sep; 16(9):14982-14999. PubMed ID: 36017992
[TBL] [Abstract][Full Text] [Related]
19. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
20. Self-delivery photodynamic-hypoxia alleviating nanomedicine synergizes with anti-PD-L1 for cancer immunotherapy.
Feng X; Chen Z; Liu Z; Fu X; Song H; Zhang Q
Int J Pharm; 2023 May; 639():122970. PubMed ID: 37084832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
